secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Health, Inc. (ODYY)
CIK:        0001626644
Form:       8-K
Filed at:   2022-04-20T23:59:59+00:00
Accession:  0001683168-22-002838
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Health adds Vice Admiral (r) Timothy Szymanski to Military Advisory Board
--------------------------------------------------------------------------------

- Vice Admiral (r) Szymanski served 36 years as Navy SEAL, most recently Deputy Commander USSOCOM.
- He established cognitive baseline policy for Special Operations and created brain health initiatives.
- Odyssey's concussion drug candidate PRV-002 is currently in Phase 1 clinical trial.
- Up to 3.8 million concussions occur annually in the U.S., with 30-50% unreported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626644/000168316822002838/0001683168-22-002838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626644/000168316822002838/ody_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-002838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer